From GlobeNewswire: 2025-03-21 07:56:00

The Blood Collection Devices Market is projected to reach $14.02 billion by 2030, growing at a CAGR of 6.1% due to increasing chronic diseases like cancer. Liquid biopsies are popular for cancer screening, aiding early detection and treatment. Key players include Becton Dickinson, Terumo Corp, and Thermo Fisher Scientific.

Grifols acquired Biotest AG while Stryker acquired Inari Medical for $4.9 billion. North America led the market in 2022, with Asia Pacific expected to show the highest growth. The market is segmented by product, application, and end-user, with a focus on technological advancements and minimally invasive diagnostics.

Innovations like capillary blood sampling and autonomous blood drawing devices cater to patients with difficult venous access, making blood collection safer and more efficient. The market is expected to see significant growth driven by the increasing demand for minimally invasive diagnostics. North America led the market in 2022, with Asia Pacific expected to show the highest growth.

For more detailed insights on the Blood Collection Devices Market, visit the provided link. The market is segmented by product, application, and end-user, with a focus on technological advancements and minimally invasive diagnostics. Key players include Becton Dickinson, Terumo Corp, and Thermo Fisher Scientific.



Read more at GlobeNewswire: Blood Collection Devices Market Size to Reach US$ 14.02